Curated Information
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.7.5
Powered by Cell Signaling Technology
Home > Curated Information Page > PubMed Id: 36384121
Spel L, et al. (2022) CDC42 regulates PYRIN inflammasome assembly. Cell Rep 41, 111636 36384121
This page summarizes selected information from the record referenced above and curated into PhosphoSitePlus®, a comprehensive online resource for the study of protein post-translational modifications (NAR, 2015, 43:D512-20). To learn more about the scope of PhosphoSitePlus®, click here.
Information from this record has been curated, but not yet edited in PhosphoSitePlus® and may be incomplete.
Click on the protein name to open the protein page, and on the RSD number to open the site page.
Download

S208-p - pyrin (human)
Modsite: VRLRRNAssAGRLQG SwissProt Entrez-Gene
Orthologous residues
pyrin (human): S208‑p, pyrin (mouse): S205‑p, pyrin (rat): Q204‑p
Characterization
Methods used to characterize site in vivo mutation of modification site
Disease tissue studied:  lymphoma
Relevant cell lines - cell types - tissues:  U-937 (myeloid)
Cellular systems studied:  cell lines
Species studied:  human

S242-p - pyrin (human)
Modsite: SGKMRPRsLEVTIST SwissProt Entrez-Gene
Orthologous residues
pyrin (human): S242‑p, pyrin (mouse): S241‑p, pyrin (rat): V238‑p
Characterization
Methods used to characterize site in vivo mutation of modification site, phospho-antibody, western blotting
Disease tissue studied:  leukemia, acute myelogenous leukemia, lymphoma
Relevant cell lines - cell types - tissues:  THP1 (myeloid), U-937 (myeloid)
Cellular systems studied:  cell lines
Species studied:  human
Upstream Regulation
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
Clostridioides difficile toxin B increase
CDC42 (human) no change compared to control CDC42 KO has no effect
CDC42 (human) increase Q61L mutant
IPA-3 CDC42 (human) inhibit treatment-induced increase
Downstream Regulation
Effect of modification (function):  activity, inhibited, molecular association, regulation
Modification regulates interactions with: 
Interacting molecule Interacting domains Effect Consequences (function) Consequences (process) Detection assays
14-3-3 beta (mouse) Induces co-immunoprecipitation